< Back to previous page

Publication

Mirvetuximab soravtansine (MIRV) in patients with platinum-resistant ovarian cancer with high folate receptor alpha (FR alpha) expression: Characterization of antitumor activity in the SORAYA study.

Journal Contribution - Journal Article Conference Contribution

Journal: JOURNAL OF CLINICAL ONCOLOGY
ISSN: 0732-183X
Issue: 16
Volume: 40
Publication year:2022

Authors/publisher

  • Ursula A Matulonis (First author)
  • Ana Oaknin (Author)
  • Sandro Pignata (Author)
  • Hannelore Denys (Author)
  • Nicoletta Colombo (Author)
  • Toon Van Gorp (Author)
  • Jason A Konner (Author)
  • Marga Romeo (Author)
  • Philipp Harter (Author)
  • Conleth G Murphy (Author)
  • Jiuzhou Wang (Author)
  • Michael W Method (Author)
  • Brooke Esteves (Author)
  • Robert L Coleman (Author)
  • Domenica Lorusso (Last author)

Research units

Events

  • Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)()

    ELECTR NETWORK